Skip to content

Impact of Exercise Combined With Inulin Propionate Ester on Fat Oxidation

Impact of Moderate Intensity Exercise Training Combined With Inulin Propionate Ester Supplementation on Whole Body Resting Fat Oxidation and Body Weigh in Overweight Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04016350
Acronym
IPE
Enrollment
20
Registered
2019-07-11
Start date
2015-02-05
Completion date
2017-06-11
Last updated
2019-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Inulin Propionate Ester

Keywords

Exercise,, Inulin Propionate Ester, Gut hormones, Body weigh, Fat oxidation, Overweight women

Brief summary

There is evidence to suggest that responsiveness to exercise training programmes can be expected to be influenced by changes in resting fat oxidation, an important factor in the aetiology of obesity. Our previous work has shown that oral supplementation with inulin propionate ester (IPE) reduces intra-abdominal fat and prevents weight gain and that oral propionate intake enhances resting fat oxidation. The effects of IPE combined with exercise training on resting fat oxidation and body fatness are unknown. The aim of this study was to investigate the impact of 4-weeks IPE supplementation, in combination with a moderate intensity exercise training programme, on whole body fat oxidation and on plasma GLP-1 and PYY.

Detailed description

Participants: Healthy overweight females with BMI \>25 kg/m2 and 25-45 years of age were recruited through advertisements and word of mouth on the campus of the University of Glasgow or from other public places. Participants were required to be sedentary, non-smokers, with stable body weight for two months prior to the study enrollment, not pregnant, free of medication, nutritional supplementation or following any specific diet and with no antibiotic use for the past three months. Participants with chronic illness, eating disorders and history of gastrointestinal operations were excluded. Study Design: This is a randomized study with a parallel design. Study participants underwent 4 week supervised moderate intensity exercise training combined either with IPE (EX/IPE) or cellulose as placebo (EX/Placebo) supplementation at doses of 10g / day. Supplements were provided as sachets containing white powder and participants were asked to consume one sachet per day with breakfast in a way convenient for each participant. Before the start of the study and at the end of the 4-week intervention, participants were asked to conduct a submaximal exercise test. Prior to the first and after the second submaximal exercise test, participants of both groups conducted a 7-hour experimental trial which involved collection of expired air and blood samples in fasted and postprandial states. Body weight and body composition were measured in the fasted state. Prior to the first 7-hour experimental trial, participants were asked to record their diet for 3 days and replicate this intake prior to the second 7-hour experimental trial.

Interventions

BEHAVIORALExercise training with Inulin Propionate Ester

Supervised moderate intensity exercise training combined with Inulin Propionate Ester supplementation conducted for 4 weeks.

Supervised moderate intensity exercise training combined with placebo conducted for 4 weeks

Sponsors

University of Glasgow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This is a randomised study with parallel design. Study participants underwent 4 week supervised moderate intensity exercise training combined either with IPE or cellulose as placebo supplementation at doses of 10g/day. Measurements were done before and after intervention

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy, sedentary and overweight females with BMI \>25 kg/m2 and stable body weight for two months prior to the study.

Exclusion criteria

Acute or chronic illness, eating disorders, history of gastrointestinal operations, smoking, pregnancy, taking supplements, and being on specific diet for the past three months.

Design outcomes

Primary

MeasureTime frameDescription
Resting fat oxidation4 weeksChanges in resting fat oxidation measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).
Resting carbohydrate oxidation4 weeksChanges in resting fat oxidation measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).
Metabolic rate4 weeksChanges in resting energy expenditure measured in the fasted and postprandial states by means of indirect calorimetry (Oxycon Pro, Germany).

Secondary

MeasureTime frameDescription
Peptide YY (PYY)4 weeksChanges in plasma concentration of fasting and postprandial PYY measured using ELISA (Merc Millipore) kit.
Body weight4 weeksChanges in body weight measured by TANITA scales (TBF-300).
Height4 weeksHeight (meters)measured by stadiometer, a vertical ruler with a sliding horizontal paddle which is adjusted to rest on the top of the head.
Glucagon-like peptide-1 (GLP-1)4 weeksChanges in plasma concentration of fasting and postprandial GLP-1 measured using ELISA (Merc Millipore) kit.
Body fat (%)4 weeksChanges in body fat expressed as percentage (proportion of fat to the total body weight) measured by TANITA scales (TBF-300).
Maximal oxygen consumption [Time Frame: 4 weeks]4 weeksChanges in maximal oxygen consumption (ml/kg/min) measured by Servomex Gas Analyser.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026